muscle weakness semaglutide and muscles Archives Semaglutide impacts skeletal muscle to

Lalonde, L

Reduction in major cardiovascular events (SELECT trial, semaglutide) Reduced risk of progressing from prediabetes to type 2 diabetes (Tirzepatide, 3yr trial) Weight reduction significantly improves sleep apnea severity confirmed in multiple GLP-1 trials Emerging ADA 2026 data on GLP-1 anti-inflammatory effects and osteoarthritis improvement Improved basal metabolic rate and energy utilisation, especially with tirzepatides GIP pathway We believe cost transparency is part of quality care

Optimising these parameters through lifestyle modification and appropriate pharmacotherapy helps reduce overall cardiovascular risk

using 2 mm punch probes